James D. Berry

Buffalo State University — United States

Medicine · Health Sciences

55h-index12.7kcitations416works6.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyotrophic Lateral Sclerosis Research(222), Neurogenetic and Muscular Disorders Research(106), Irrigation Practices and Water Management(74), Plant Physiology and Cultivation Studies(74), Greenhouse Technology and Climate Control(74)

Publications409 total

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration·2025· 1 citedOpen Access
What can vowel acoustics reveal about the communicative participation of people living with ALS?
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration·2025
Multiscale Spatial Transcriptomic Atlas of Human Basal Ganglia Cell-Type and Cellular Community Organization
2025· 2 citedOpen Access
Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis
Scientific Reports·2025· 1 citedOpen Access
Participation in U.S.‐Based <scp>ALS</scp> Clinical Trials by Sex and Race
Muscle & Nerve·2025Open Access
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis 9119
The Journal of Immunology·2025Open Access
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Nature Neuroscience·2025· 10 citedOpen Access
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
Nature·2025· 6 citedOpen Access
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study
Annals of Neurology·2025· 1 citedOpen Access
Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States
European Journal of Neurology·2025Open Access
Cardiac Troponin T in Tofersen‐Treated <scp>SOD1 ALS</scp> Patients: Beginning to Resolve the Catch‐22 of Identifying Treatment Responsive Biomarkers in <scp>ALS</scp> Drug Development
Muscle & Nerve·2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis
Muscle & Nerve·2025· 1 citedOpen Access
Design considerations for <i>C9orf72</i> disease prevention trials
Brain·2025· 2 citedOpen Access
Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis
2025Open Access
Pridopidine treatment benefits in definite, probable, and early (&lt;18mo onset) subjects with ALS in the HEALEY ALS Platform Trial
Neurotherapeutics·2025Open Access
Variability across versions of the self-administered ALSFRS-R: a review and call for harmonization
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration·2025· 2 cited
Plasma brain-derived tau and phosphorylated tau at T181 are elevated in amyotrophic lateral sclerosis
2025· 2 citedOpen Access
Reliable monitoring of respiratory function with home spirometry in people living with amyotrophic lateral sclerosis
Frontiers in Neurology·2025Open Access
CNM-Au8 in Amyotrophic Lateral Sclerosis—Reply
JAMA·2025
Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index–Remote
American Journal of Speech-Language Pathology·2025Open Access
page 1 of 21Next →

Frequent Co-authors

Merit Cudkowicz(26), Sabrina Paganoni(12), Robert H. Brown(9), Jeremy M. Shefner(8), Jonathan Katz(7), Alexander Sherman(7), Timothy M. Miller(7), Robert Bowser(7), Eric A. Macklin(6), Margaret Owegi(6), Terry Heiman‐Patterson(6), Shafeeq Ladha(6), Namita Goyal(6), Lindsay Pothier(6), Hemali Phatnani(6), Robert H. Baloh(6), Gary L. Pattee(5), Suma Babu(5), Hong Yu(5), Nazem Atassi(5)